Bone mineral density screening should be routine in lymphoma patients.

Thompson, M A; Westin, J R; Hagemeister, F B

Thompson, M A; Westin, J R; Hagemeister, F B.

Afiliación

Thompson MA; Aurora Research Institute, Aurora Health Care, Milwaukee. Electronic address: michael.a.thompson@aurora.org.
Westin JR; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
Hagemeister FB; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.

Ann Oncol ; 25(4): 913-914, 2014 Apr.

Article en En | MEDLINE | ID: mdl-24667725

Asunto(s)

Antineoplásicos/uso terapéutico; Resorción Ósea/sangre; Linfoma/tratamiento farmacológico; Femenino; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Resorción Ósea / Linfoma / Antineoplásicos Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google